Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
4
Rounds led
1
Rounds' value
$141.0M
total disclosed, rounds participated
Stages
—
Portfolio · 2
Investment activity
Portfolio by sector
Health Tech & Life Sciences2
Q&A
- What is Forbion Capital Partners' primary investment focus by sector?
- Forbion Capital Partners primarily focuses on the Health Tech & Life Sciences sector, with all of its identified portfolio companies and investment rounds falling within this area.
- Can you name some of Forbion Capital Partners' portfolio companies?
- Forbion Capital Partners' portfolio includes Prilenia Therapeutics, which develops treatments for neurodegenerative diseases, and novoGi, focused on GI disease management.
- What is the typical investment stage for Forbion Capital Partners?
- Forbion Capital Partners has participated in various stages, including A Round, B Round, and F Round investments. They have made two follow-on investments at the B Round stage.
- What was Forbion Capital Partners' most recent investment activity?
- Forbion Capital Partners made an investment in April 2022, following another in November 2021.
- What is the investment range for Forbion Capital Partners?
- Forbion Capital Partners' investment range is between $11M and $68.5M.
- When was Prilenia Therapeutics founded and what is its business model?
- Prilenia Therapeutics, a portfolio company of Forbion Capital Partners, was founded in 2018 and operates with a B2B business model.
- What was the last funding round for Prilenia Therapeutics that Forbion Capital Partners participated in?
- Forbion Capital Partners participated in a B Round for Prilenia Therapeutics, which raised $144.5M.